Product Description: Lyt-200 is a humanized monoclonal antibody targeting Galectin-9. Lyt-200 exhibits potent inhibitory effects on hematological cancer cells and can also be used in combination with methotrexate (HY-14519) for research purposes[1].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]Curtis J Henry, et al. Lyt-200, a Humanized Anti-Galectin-9 Antibody, Exhibits Preclinical Efficacy in Models of Hematological Malignancies. Blood. 2022 November 15,140 (Supplement 1): 8837.
Molecular Weight: N/A
Research Area: Cancer
Target: Galectin